Rodés J - Search Results

1

Treatment of chronic hepatitis B in children with recombinant alfa interferon. Different response according to age at infection.

Bruguera M, Amat L, Garcia O, Lambruschini N, Carnicer J, Bergada A, Martin Orte E, Costa J, Sanchez-Tapias JM, Rodés J. Bruguera M, et al. Among authors: rodes j. J Clin Gastroenterol. 1993 Dec;17(4):296-9. doi: 10.1097/00004836-199312000-00006. J Clin Gastroenterol. 1993. PMID: 8308214 Clinical Trial.

2

Toxic neuropathy after adenine arabinoside treatment in chronic HBsAg-positive liver disease.

Kanterewicz E, Bruguera M, Viola C, Lamarca J, Rodés J. Kanterewicz E, et al. Among authors: rodes j. J Clin Gastroenterol. 1990 Feb;12(1):90-2. doi: 10.1097/00004836-199002000-00023. J Clin Gastroenterol. 1990. PMID: 1689332

3

Incidence and features of liver disease in patients on chronic hemodialysis.

Bruguera M, Vidal L, Sanchez-Tapias JM, Costa J, Revert L, Rodes J. Bruguera M, et al. Among authors: rodes j. J Clin Gastroenterol. 1990 Jun;12(3):298-302. doi: 10.1097/00004836-199006000-00013. J Clin Gastroenterol. 1990. PMID: 2113936

4

Chronic hepatitis D in intravenous drug addicts and non-addicts. A comparative clinico-pathological study.

Buti M, Mas A, Sánchez-Tapias JM, Esteban R, Bruguera M, Allende H, Costa J, Guardia J, Rodés J. Buti M, et al. Among authors: rodes j. J Hepatol. 1988 Oct;7(2):169-74. doi: 10.1016/s0168-8278(88)80479-3. J Hepatol. 1988. PMID: 3192921

5

Immunogenicity of a recombinant hepatitis B vaccine in haemodialysis patients.

Bruguera M, Cremades M, Mayor A, Sánchez Tapias JM, Rodés J. Bruguera M, et al. Among authors: rodes j. Postgrad Med J. 1987;63 Suppl 2:155-8. Postgrad Med J. 1987. PMID: 3317354 Clinical Trial.

6

Analysis of factors predicting early seroconversion to anti-HBe in HBeAg-positive chronic hepatitis B.

Sánchez-Tapias JM, Costa J, Mas A, Parés A, Bruguera M, Rodés J. Sánchez-Tapias JM, et al. Among authors: rodes j. J Hepatol. 1988 Feb;6(1):15-22. doi: 10.1016/s0168-8278(88)80458-6. J Hepatol. 1988. PMID: 3346532

7

Recombinant alpha 2c-interferon therapy in fulminant viral hepatitis.

Sánchez-Tapias JM, Mas A, Costa J, Bruguera M, Mayor A, Ballesta AM, Compernolle C, Rodés J. Sánchez-Tapias JM, et al. Among authors: rodes j. J Hepatol. 1987 Oct;5(2):205-10. doi: 10.1016/s0168-8278(87)80574-3. J Hepatol. 1987. PMID: 3693864

8

Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum.

Ampurdanés S, Olmedo E, Maluenda MD, Forns X, López-Labrador FX, Costa J, Sánchez-Tapias JM, de Anta MT, Rodés J. Ampurdanés S, et al. Among authors: rodes j. J Hepatol. 1996 Dec;25(6):827-32. doi: 10.1016/s0168-8278(96)80285-6. J Hepatol. 1996. PMID: 9007709

9

Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy.

Sáiz JC, Ampurdanés S, Olmedo E, López-Labrador FX, Forns X, Guilera M, Tassies D, Costa J, Sánchez-Tapias JM, Jiménez de Anta MT, Rodés J. Sáiz JC, et al. Among authors: rodes j. J Hepatol. 1997 Apr;26(4):787-93. doi: 10.1016/s0168-8278(97)80243-7. J Hepatol. 1997. PMID: 9126790

10

Hepatology. Interferon in chronic hepatitis C.

Sánchez-Tapias JM, Rodés J. Sánchez-Tapias JM, et al. Among authors: rodes j. Lancet. 1995 Dec 23-30;346 Suppl:s11. doi: 10.1016/0140-6736(95)90010-1. Lancet. 1995. PMID: 9454028 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

730 results

Search Page

Filters